AFRM stock jumped nearly 13% on Monday after Goldman Sachs offered a "buy" rating and a lofty $42 price target. More
Articles
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
These are the undervalued pharma stocks and represent companies with a deep research pipeline, that provides sustained growth visibility. More
7 Retail Stocks to Buy on the Dip: June 2024
After a steady slide or a post-earnings pullback, these seven retail stocks to buy on the dip have entered bargain territory. More
3 Underrated AI Stocks With Serious Upside Potential
The underrated AI stocks may be intriguing candidates to watch as the tech scene begins to head lower after a strong first half. More
A Big Change Is Coming to America This Year – Are You Prepared?
I know this prediction is distressing, but if you pay close attention during my Prediction 2024 event, you could come out ahead. More
3 AI Stocks to Buy on the Dip: June 2024
Artificial tailwinds are still blowing strong for these top AI stocks to buy. Even though they have big gains, more returns look likely. More
No Brainer Buys: 3 Mid-Cap Stocks Set to Surge 50% or More by 2028
Don't miss out. These unstoppable mid-cap stocks to buy could surge 50% or more by 2028 with the new bull market underway in 2024. More
